当前位置:首页 - 行情中心 - 佛慈制药(002644) - 财务分析 - 现金流量表

佛慈制药

(002644)

  

流通市值:39.22亿  总市值:39.22亿
流通股本:5.11亿   总股本:5.11亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金713,074,841.52505,443,465.26214,169,482.28887,026,778.36
  收到的税费返还6,159,088.995,048,823.821,721,960.896,246,198.36
  收到其他与经营活动有关的现金57,343,406.8728,337,558.8717,602,684.9350,125,956.55
  经营活动现金流入小计776,577,337.38538,829,847.95233,494,128.1943,398,933.27
  购买商品、接受劳务支付的现金305,788,919.9193,997,416.5886,635,597.02352,926,756.11
  支付给职工以及为职工支付的现金116,226,689.3179,352,218.5140,327,442.77151,360,204.29
  支付的各项税费73,473,015.9955,961,874.9827,216,883.11106,821,009.48
  支付其他与经营活动有关的现金88,579,992.5449,158,969.1223,326,634.33148,341,615.92
  经营活动现金流出小计584,068,617.74378,470,479.19177,506,557.23759,449,585.8
  经营活动产生的现金流量净额192,508,719.64160,359,368.7655,987,570.87183,949,347.47
二、投资活动产生的现金流量:
  取得投资收益收到的现金-392,671.23--
  处置固定资产、无形资产和其他长期资产收回的现金净额---270,312.73
  投资活动现金流入的平衡项目-0-0
  投资活动现金流入小计-392,671.23-270,312.73
  购建固定资产、无形资产和其他长期资产支付的现金28,464,290.8625,677,935.831,798,162.1918,548,451.06
  投资支付的现金---20,000,000
  支付其他与投资活动有关的现金---18,867.92
  投资活动现金流出小计28,464,290.8625,677,935.831,798,162.1938,567,318.98
  投资活动产生的现金流量净额-28,464,290.86-25,285,264.6-1,798,162.19-38,297,006.25
三、筹资活动产生的现金流量:
  取得借款收到的现金2,000,0002,000,000016,000,000
  筹资活动现金流入小计2,000,0002,000,000016,000,000
  偿还债务支付的现金26,436,80016,436,80013,200,00023,900,000
  分配股利、利润或偿付利息支付的现金10,584,905.7910,515,461.34239,233.337,024,032.6
  支付其他与筹资活动有关的现金---928,892.78
  筹资活动现金流出小计37,021,705.7926,952,261.3413,439,233.3331,852,925.38
  筹资活动产生的现金流量净额-35,021,705.79-24,952,261.34-13,439,233.33-15,852,925.38
四、汇率变动对现金及现金等价物的影响----188,980.2
五、现金及现金等价物净增加额129,022,722.99110,121,842.8240,750,175.35129,610,435.64
  加:期初现金及现金等价物余额524,492,565.97524,492,565.97524,492,565.97394,882,120.33
  期末现金及现金等价物余额653,515,288.96634,614,408.79565,242,741.32524,492,555.97
补充资料:
  净利润-37,955,735.58-46,955,016.44
  资产减值准备-7,457,061.83-58,440,046.99
  固定资产和投资性房地产折旧-29,625,854.3-50,658,704.67
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-29,625,854.3-50,658,704.67
  无形资产摊销-1,646,798.46-3,433,417.49
  长期待摊费用摊销-755,402.29-3,608,545.08
  处置固定资产、无形资产和其他长期资产的损失----7,131,603.77
  固定资产报废损失----270,312.73
  财务费用-548,392.88-944,455.11
  投资损失-2,771,744.55-13,537,423.9
  递延所得税-1,931,219.77--4,614,497.68
  其中:递延所得税资产减少-1,347,112.84--3,982,866.39
    递延所得税负债增加-584,106.93--631,631.29
  存货的减少--18,582,162.57-48,357,921.3
  经营性应收项目的减少--63,409,437.28--86,743,167.15
  经营性应付项目的增加-158,801,725.28-55,562,229.23
  现金的期末余额-634,614,408.79-524,492,555.97
  减:现金的期初余额-524,492,565.97-394,882,120.33
  现金及现金等价物的净增加额-110,121,842.82-129,610,435.64
公告日期2026-10-292026-08-202026-04-302026-04-09
审计意见(境内)标准无保留意见
TOP↑